DRMAW Dermata Therapeutics, Inc. - Warrant
$0.02
가격 · 5월 19, 2026
기준 재무 정보 5월 13, 2026
DRMAW 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$0.02
시가총액
—
P/E (TTM)
—
EPS (TTM)
$-8.16
매출 (TTM)
—
배당 수익률
—
ROE
-127.7%
부채/자본
—
52주 범위
$0 – $0
DRMAW 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
—
EPS
$-8.16
2023-12-31
→
2025-12-31
잉여현금흐름
—
마진
—
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
DRMAW
동종업계 중앙값
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
DRMAW
동종업계 중앙값
ROA
-132.6%
—
ROE
-127.7%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
DRMAW
동종업계 중앙값
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
DRMAW
동종업계 중앙값
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
DRMAW
동종업계 중앙값
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $8M | $4M | $6M | $3M | $2M | |
| SG&A Expense | $5M | $4M | $4M | $4M | $4M | $2M | |
| Operating Expenses | $8M | $13M | $8M | $10M | · | · | |
| Operating Income | $-8M | $-13M | $-8M | $-10M | $-8M | $-3M | |
| Interest Expense | · | · | · | · | $45.6K | $197.3K | |
| Interest Income | $215.0K | $225.8K | · | · | · | · | |
| Income Tax | · | · | $0 | $0 | $0 | $0 | |
| Net Income | $-8M | $-12M | $-8M | $-10M | $-8M | $-3M | |
| EPS (Basic) | $-8.16 | $-80.32 | $-39.99 | $-13.92 | $-2.43 | $-1.69 | |
| EPS (Diluted) | $-8.16 | $-80.32 | $-39.99 | · | · | · | |
| Shares (Basic) | 926,192 | 152,974 | · | · | 4,302,232 | 1,911,009 | |
| Shares (Diluted) | 926,192 | 152,974 | 194,928 | · | · | · | |
| EBITDA | $-8M | $-13M | $-8M | · | $-8M | · |
대차대조표 15
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $3M | · | $6M | $11M | $530.4K | |
| Prepaid Expense | $341.8K | $372.3K | $540.5K | $703.2K | $825.1K | $75.1K | |
| Current Assets | · | · | · | · | $12M | $605.5K | |
| PP&E (Net) | · | · | · | · | $0 | $0 | |
| Total Assets | $8M | $4M | $8M | $7M | $12M | $605.5K | |
| Accounts Payable | $460.8K | $808.0K | $866.0K | $496.7K | $515.2K | $104.3K | |
| Current Liabilities | · | · | · | · | $2M | $4M | |
| Total Liabilities | $2M | $2M | $2M | $922.6K | $2M | $4M | |
| Total Debt | · | · | · | · | $0 | · | |
| Common Stock | $266 | $25 | $26 | $77 | $833 | $0 | |
| Paid-in Capital | $79M | $67M | $60M | $52M | $46M | $0 | |
| Retained Earnings | $-73M | $-66M | $-53M | $-46M | $-36M | $-28M | |
| Stockholders' Equity | $6M | $2M | $6M | $6M | $10M | $-3M | |
| Liabilities + Equity | $8M | $4M | $8M | $7M | $12M | $605.5K | |
| Shares Outstanding | 2,660,110 | 251,725 | 261,998 | 770,115 | 8,328,629 | · |
현금 흐름 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $0 | $322 | |
| Stock-based Comp | $143.7K | $657.6K | $522.1K | $930.3K | $2M | $0 | |
| Operating Cash Flow | $-8M | $-11M | $-6M | $-9M | $-6M | $-4M | |
| Stock Issued | $12M | $7M | $8M | $4M | $15M | · | |
| Net Stock Activity | $12M | $7M | $8M | · | · | · | |
| Financing Cash Flow | $12M | $7M | $8M | $4M | $16M | $3M | |
| Net Change in Cash | $4M | $-4M | · | · | $10M | $-1M |
수익성 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -132.6% | -213.5% | -104.5% | · | -129.2% | · | |
| ROE | -127.7% | -389.9% | -122.2% | · | -69.9% | · |
유동성 및 지급능력 4
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | 7.7 | · | |
| Quick Ratio | · | · | · | · | 7.1 | · | |
| Debt / Equity | · | · | · | · | 0.0 | · | |
| Interest Coverage | · | · | · | · | -172.3 | · |
가치 평가 (TTM) 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $182.8K | $182.8K | $182.8K | $63.6K | $-45.6K | · | |
| Net Income TTM | $-8M | $-12M | $-8M | $-10M | $-8M | · |
손익계산서 12
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $383.7K | $526.6K | $504.4K | $617.8K | $1M | $2M | $2M | $2M | $2M | $1M | $903.0K | $838.9K | $1M | $889.4K | $2M | $2M | |
| SG&A Expense | $2M | $1M | $1M | $1M | $1M | $1M | $824.3K | $874.6K | $2M | $1M | $909.0K | $893.5K | $1M | $822.3K | $892.8K | $1M | |
| Operating Expenses | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Operating Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Interest Income | $78.7K | $38.5K | $68.7K | $71.6K | $36.2K | $49.4K | $52.5K | $54.6K | $69.3K | · | · | · | · | · | · | · | |
| Net Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | |
| EPS (Basic) | $-0.48 | $-4.40 | $-1.65 | $-1.66 | $-4.47 | $-11.03 | $-20.41 | $-41.82 | $-7.06 | $-36.55 | $-0.54 | $-0.63 | $-2.27 | $-6.53 | $-3.16 | $-3.90 | |
| EPS (Diluted) | $-0.48 | $-4.40 | $-1.65 | $-1.66 | $-4.47 | $-11.03 | $-20.41 | $-41.82 | $-7.06 | · | · | · | · | · | · | · | |
| Shares (Basic) | 3,858,921 | -6,281,469 | 1,026,457 | 1,026,506 | 515,465 | -514,143 | 155,465 | 67,654 | 443,998 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 3,858,921 | -6,281,469 | 1,026,457 | 1,026,506 | 515,465 | -514,143 | 155,465 | 67,654 | 443,998 | · | · | · | · | · | · | · | |
| EBITDA | $-2M | · | $-2M | $-2M | $-2M | · | $-3M | $-3M | $-3M | · | $-2M | $-2M | $-2M | · | $-2M | $-3M |
대차대조표 12
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $8M | $5M | $6M | $10M | $3M | · | · | · | · | $7M | $8M | $9M | · | $8M | $11M | |
| Inventory | $93.1K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $427.3K | $341.8K | $407.3K | $159.6K | $285.7K | $372.3K | $543.6K | $289.5K | $446.1K | $540.5K | $691.9K | $274.4K | $528.3K | $703.2K | $908.1K | $398.5K | |
| Total Assets | $7M | $8M | $5M | $7M | $10M | $4M | $7M | $5M | $5M | $8M | $7M | $9M | $9M | $7M | $9M | $11M | |
| Accounts Payable | $318.3K | $460.8K | $453.4K | $413.7K | $1M | $808.0K | $863.6K | $1M | $822.5K | $866.0K | $474.5K | $437.8K | $492.9K | $496.7K | $483.7K | $608.8K | |
| Total Liabilities | $1M | $2M | $1M | $1M | $3M | $2M | $2M | $2M | $1M | $2M | $916.8K | $682.9K | $1M | $922.6K | $2M | $1M | |
| Common Stock | $402 | $266 | $84 | $64 | $603 | $25 | $168 | $69 | $666 | $26 | $319 | $319 | $239 | $77 | $1.2K | $1.0K | |
| Paid-in Capital | $81M | $79M | $75M | $75M | $75M | $67M | $67M | $63M | $60M | $60M | $58M | $58M | $56M | $52M | $51M | $51M | |
| Retained Earnings | $-75M | $-73M | $-71M | $-70M | $-68M | $-66M | $-63M | $-59M | $-57M | $-53M | $-51M | $-50M | $-48M | $-46M | $-44M | $-41M | |
| Stockholders' Equity | $6M | $6M | $4M | $6M | $7M | $2M | $5M | $3M | $4M | $6M | $6M | $8M | $8M | $6M | $7M | $10M | |
| Liabilities + Equity | $7M | $8M | $5M | $7M | $10M | $4M | $7M | $5M | $5M | $8M | $7M | $9M | $9M | $7M | $9M | $11M | |
| Shares Outstanding | 4,022,143 | 2,660,110 | 844,457 | 637,757 | 6,032,648 | 251,725 | 1,677,768 | 693,175 | 6,660,840 | 261,998 | 3,189,034 | 3,189,034 | 2,388,157 | 770,115 | 12,102,214 | 10,102,214 |
현금 흐름 6
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $43.3K | $29.5K | $37.8K | $39.2K | $37.2K | $29.8K | $21.0K | $19.6K | $587.2K | $128.5K | $131.2K | $131.2K | $131.3K | $220.9K | $235.0K | $261.6K | |
| Operating Cash Flow | $-2M | $-1M | $-2M | $-3M | $-2M | $-3M | $-3M | $-2M | $-3M | $-1M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | |
| Stock Issued | · | $4M | $-12.6K | $-547.9K | $9M | $-69.5K | $5M | $2M | · | $2M | $-35.4K | $2M | $4M | $0 | $0 | $4M | |
| Net Stock Activity | · | · | · | · | $9M | · | · | · | $0 | · | · | · | $4M | · | · | · | |
| Financing Cash Flow | $2M | $4M | $-13.0K | $-547.9K | $8M | $-68.6K | $5M | $2M | · | $2M | $-35.4K | $2M | $4M | $0 | $200 | $4M | |
| Net Change in Cash | $-576.7K | $3M | $-2M | $-3M | $7M | $-3M | $1M | $213.4K | $-3M | · | · | · | · | · | · | · |
수익성 5
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | -1953.3% | -5579.4% | -6067.3% | · | 11384.5% | · | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | -1853.3% | -5479.4% | -5967.3% | · | 11284.5% | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | -1953.3% | -5579.4% | -6067.3% | · | 11384.5% | · | |
| ROA | -21.1% | · | -28.8% | -28.6% | -30.3% | · | -45.3% | -40.6% | -43.3% | · | -21.1% | -17.2% | -24.4% | · | -21.4% | -44.9% | |
| ROE | -27.0% | · | -38.9% | -38.1% | -41.5% | · | -56.9% | -49.9% | -52.7% | · | -24.8% | -19.2% | -28.1% | · | -24.3% | -59.7% |
효율성 1
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | -0.0 | · |
가치 평가 (TTM) 9
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $182.8K | · | $182.8K | $182.8K | $182.8K | · | $182.8K | $182.8K | $182.8K | · | $182.8K | $90.1K | $59.0K | · | $22.1K | · | |
| Net Income TTM | $-8M | · | $-9M | $-10M | $-11M | · | $-11M | $-9M | $-9M | · | $-8M | $-9M | $-10M | · | $-10M | $-9M | |
| Market Cap | $73.6K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | 0.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -45136.6% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 순이익 | $-8M | $-12M | $-8M | $-10M | $-8M |
| 희석 EPS | $-8.16 | $-80.32 | $-39.99 | — | — |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | — | — | — | — | 0.0 |
| 유동비율 | — | — | — | — | 7.7 |
| 당좌 비율 | — | — | — | — | 7.1 |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.